ProCE Banner Activity

Sotatercept Active in Patients With Myeloproliferative Neoplasm–Associated Anemia

Slideset Download
Conference Coverage
Sotatercept well tolerated with response observed in 36% of evaluable patients.

Released: December 08, 2016

Expiration: December 07, 2017

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Seagen